Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$10.76
-4.9%
$13.11
$9.39
▼
$16.29
$476.06M0.3508,450 shs612,488 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$74.86
-1.0%
$81.01
$73.68
▼
$118.01
$1.73B0.51287,289 shs250,300 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$688.91
-0.6%
$677.47
$435.27
▼
$727.56
$256.67B0.842.01 million shs1.98 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$397.16
-1.7%
$385.77
$223.83
▼
$438.27
$28.14B1.13772,442 shs819,217 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-4.95%-10.18%-8.89%-31.68%-9.58%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
-0.95%-3.59%-10.24%-8.55%-13.76%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-0.50%-1.52%+0.17%+9.52%+20.15%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-1.84%-3.55%+2.19%+12.53%+53.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$10.76
-4.9%
$13.11
$9.39
▼
$16.29
$476.06M0.3508,450 shs612,488 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$74.86
-1.0%
$81.01
$73.68
▼
$118.01
$1.73B0.51287,289 shs250,300 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$688.91
-0.6%
$677.47
$435.27
▼
$727.56
$256.67B0.842.01 million shs1.98 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$397.16
-1.7%
$385.77
$223.83
▼
$438.27
$28.14B1.13772,442 shs819,217 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-4.95%-10.18%-8.89%-31.68%-9.58%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
-0.95%-3.59%-10.24%-8.55%-13.76%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-0.50%-1.52%+0.17%+9.52%+20.15%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-1.84%-3.55%+2.19%+12.53%+53.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
2.60
Moderate Buy$19.0076.58% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.38
Hold$108.2544.60% Upside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.93
Moderate Buy$683.64-0.76% Downside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.93
Moderate Buy$424.676.93% Upside

Current Analyst Ratings Breakdown

Latest ANGO, TMO, WST, and LMAT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Lower Price TargetEqual Weight$94.00 ➝ $86.00
11/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Reiterated RatingMarket Outperform
11/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Initiated CoverageMarket Outperform$127.00 ➝ $110.00
11/2/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
UpgradeHold (C+) ➝ Buy (B-)
11/2/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Reiterated RatingBuy$475.00
10/30/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Boost Price TargetBuy$560.00 ➝ $780.00
10/30/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Boost Price TargetBuy$412.00 ➝ $494.00
10/30/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Boost Price TargetBuy$420.00 ➝ $500.00
10/30/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Boost Price TargetOverweight$440.00 ➝ $500.00
10/28/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Lower Price TargetOutperform$720.00 ➝ $615.00
10/23/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
DowngradeBuy (B-) ➝ Hold (C+)
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$320.17M1.41$0.30 per share36.18$4.13 per share2.61
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$249.60M6.86$2.87 per share26.04$18.89 per share3.96
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$44.56B5.73$30.23 per share22.79$147.81 per share4.66
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$3.07B9.00$9.57 per share41.49$42.61 per share9.32
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$36.74M-$0.78N/AN/AN/A-10.12%-4.49%-2.96%1/6/2027 (Estimated)
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$57.73M$2.7527.4823.772.2323.51%15.33%9.97%N/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.70B$18.9628.0224.772.8214.94%17.33%8.18%2/4/2027 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$493.70M$8.9144.5738.862.4618.81%21.78%15.99%N/A

Latest ANGO, TMO, WST, and LMAT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.6860$0.65-$0.0360$0.65$67.39 million$67.97 million
10/29/2026Q3 2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.20$2.66+$0.46$3.02$827.12 million$874.50 million
10/21/2026Q3 2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.40$6.68+$0.28$4.64$11.95 billion$12.14 billion
10/8/2026Q1 2027
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$0.1125-$0.04+$0.0725-$0.17$80.51 million$80.92 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$1.001.34%+16.05%36.36%14 Years
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.880.27%+14.34%9.92%8 Years
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.040.26%+5.51%11.67%N/A

Latest ANGO, TMO, WST, and LMAT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/5/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.470.28%12/15/202612/15/20261/15/2027
10/27/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.251.34%11/19/202611/19/202612/3/2026
10/19/2026
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.260.25%11/10/202611/11/202611/18/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/A
2.40
1.48
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.39
14.60
12.54
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.71
1.81
1.41
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.07
2.82
2.10

Institutional Ownership

CompanyInstitutional Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
89.43%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
63242.05 million39.53 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
65522.88 million21.19 millionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000370.52 million369.29 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,80069.66 million69.24 millionOptionable

Recent News About These Companies

West to Participate in Upcoming Investor Conference

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AngioDynamics stock logo

AngioDynamics NASDAQ:ANGO

$10.76 -0.56 (-4.95%)
Closing price 11/19/2026 04:00 PM Eastern
Extended Trading
$10.76 +0.01 (+0.05%)
As of 11/19/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$74.86 -0.72 (-0.95%)
Closing price 11/19/2026 04:00 PM Eastern
Extended Trading
$74.86 0.00 (0.00%)
As of 11/19/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$688.91 -3.83 (-0.55%)
Closing price 11/19/2026
Extended Trading
$691.40 +2.49 (+0.36%)
As of 11/19/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$397.16 -6.86 (-1.70%)
Closing price 11/19/2026 03:59 PM Eastern
Extended Trading
$389.67 -7.49 (-1.89%)
As of 11/19/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.